biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Response to TheTruth1234 - Lots of Fun Ahead

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Apr 16, 2023 7:20pm

99 Views

Post# 35397626

RE:RE:Response to TheTruth1234 - Lots of Fun Ahead

Come to think about it, its kind of ironic that JD flagged my post for "Bullying".

Over the past 10 years or so, how many of you who spoke negatively about Bioasis or about JD received a DM or reply from JD that he is going to:

-Sue the individual,
-Is going to "reveal" the posters identity
-Share /post private emails shared with him
-blah blah blah

In fact, if you read JDs reply to me about Dan, he threatened "reveal emails from Dan".

Man, you cant make this stuff up!!!

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Jan. 10, 2025)